Pro Vape Challenges Latvia's E-Cigarette Flavor Ban in Court

Regulations by 2FIRSTS.ai
Jul.02.2024
Pro Vape Challenges Latvia's E-Cigarette Flavor Ban in Court
Pro Vape challenges Latvia's e-cigarette flavor ban, questioning constitutionality, seeking review by Constitutional Court.

According to a report by LETA on July 2, the manufacturer of the Latvian e-cigarette brand "Salt", Pro Vape, has raised concerns with the Constitutional Court (ST) regarding the proposed ban on e-cigarette flavors next year.


The Constitutional Court has taken up the case and will assess whether the amendments to the "Tobacco Products, Tobacco Alternatives, Smoking Herbal Products, E-Cigarette Devices and their Liquid Refills Act" passed by Parliament earlier this year comply with the first three clauses of Article 105 of the Constitution.


According to the amendment, starting from next year, Latvia will prohibit the sale of flavored e-cigarette liquids and tobacco alternative products.


Pro Vape has raised objections to these provisions in the revised law.


The company requested an evaluation to determine whether these changes are compatible with the first three sentences of Article 105 of the Constitution. Article 105 of the Constitution stipulates that every person in Latvia has the right to property, that property cannot be used for purposes contrary to the public interest, and that property rights may be limited by law.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
Philip Morris Japan adds “Electric Purple” to IQOS ILUMA i range, expands to convenience stores from Feb. 3
Philip Morris Japan adds “Electric Purple” to IQOS ILUMA i range, expands to convenience stores from Feb. 3
Philip Morris Japan (PMJ) said on Jan. 29 it has introduced “Electric Purple” as a new standard color option for its IQOS ILUMA i heated tobacco device lineup, covering three models with prices unchanged. The new color will be available from Jan. 29 via the company’s official online and store channels, with sales expanding to convenience stores and some tobacco retailers from Feb. 3.
Jan.29 by 2FIRSTS.ai
Malaysia joint operation seized $19,000 worth of vape liquid in Likas
Malaysia joint operation seized $19,000 worth of vape liquid in Likas
More than 2,300 units of vape liquid worth over RM75,000 were seized during an integrated operation at premises in Likas near Kota Kinabalu. During Ops Taring Landai E-Cigarette Mega on Feb 10 night, the Marine Police, Sabah Health Department officials and district police detected a shop displaying 92 types of vape pods and, after further searches, found 2,353 units of vape liquid stored on the premises.
Feb.11 by 2FIRSTS.ai
IQOS Japan launches three ILUMA i custom bundle sets with leather wrap and premium ring accessories, on sale from Jan 29
IQOS Japan launches three ILUMA i custom bundle sets with leather wrap and premium ring accessories, on sale from Jan 29
According to IQOS Japan’s official website, the company has introduced three custom bundle sets for its IQOS ILUMA i lineup, combining devices with accessories as bundled offerings, and began rolling them out across multiple sales channels from Jan. 29.
Jan.29 by 2FIRSTS.ai
Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
The Irish government has approved the publication of the Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026. The bill would ban the sale of nicotine consumption products such as nicotine pouches to those under 18 and further regulate nicotine vaping products.
Mar.05 by 2FIRSTS.ai
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Group (Nasdaq: XXII) reported early commercial momentum for its FDA-authorized VLN® very low nicotine cigarettes, distributing approximately 8,800 cartons across 1,700 new U.S. retail outlets in the fourth quarter of 2025, while forecasting expansion to more than 5,000 retail points in 2026.
Business
Feb.24